Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
6.4%+1.7pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$41.1M-10.7%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$6.95M-19.1%
Alumis Inc. logo
Alumis Inc.ALMS
$15.95M+12.1%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$4.25M+146%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$5.04M+61.4%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.94B+1,017%
Enterprise value$5.89B+1,158%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemMarch 31, 2026December 31, 2025
Total current assets395,249343,857
Marketable securities, long-term107,123142,539
Property and equipment, net318288
Operating lease right-of-use assets1,6871,830
Other non-current assets103103
Total assets$504,480$488,617
Liabilities and Stockholders’ Equity
Current liabilities:

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s operating lease ROU assets?
Oruka Therapeutics, Inc. (ORKA) reported operating lease ROU assets of $1.69M in Q1 2026.
How has Oruka Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Oruka Therapeutics, Inc.'s operating lease ROU assets increased by 107.2% year-over-year, from $814K to $1.69M.
What is the long-term trend for Oruka Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s operating lease ROU assets has grown at a 33.7% compound annual growth rate (CAGR), from $428K to $1.83M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Oruka Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude